Aradigm Announces Second Quarter 2017 Financial Results

07:00 EDT 10 Aug 2017 | Businesswire
This article has expired, however you can still download the PDF.
Aradigm Corporation (NASDAQ: ARDM) (the “Company”) today announced financial results for the second quarter and six months ended June 30, 2017. The Company recorded $7.7 million in revenue in the second quarter of ...

Other Sources for this Article

Aradigm Corporation
Nancy Pecota, 510-265-8800
Chief Financial Officer


More From BioPortfolio on "Aradigm Announces Second Quarter 2017 Financial Results"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...